世界のエクソソーム診断学＆治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Exosome Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3432 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：産業装置

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、エクソソーム診断学＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬、ソフトウェア）、用途別市場規模（診断、治療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・エクソソーム診断学＆治療の市場動向 ・企業の競争状況、市場シェア ・エクソソーム診断学＆治療の種類別市場規模と予測2016-2027（機器、試薬、ソフトウェア） ・エクソソーム診断学＆治療の用途別市場規模と予測2016-2027（診断、治療） ・エクソソーム診断学＆治療の北米市場規模2016-2027（アメリカ、カナダ） ・エクソソーム診断学＆治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・エクソソーム診断学＆治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エクソソーム診断学＆治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・エクソソーム診断学＆治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Aethlon Medical(US)、Exosome Diagnostics(US)、NanoSomix Inc.(US)、Thermo Fisher Scientific (US)、Malvern Instruments (UK)、System Biosciences(US)、NX Pharmagen (US)、Sistemic Inc(UK)、Capricor Therapeutics (US)、Exiqon A/S (Denmark)） ・結論

Market Analysis and Insights: Global Exosome Diagnostics and Therapeutics Market
The global Exosome Diagnostics and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Exosome Diagnostics and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Exosome Diagnostics and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Exosome Diagnostics and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Exosome Diagnostics and Therapeutics market.

Global Exosome Diagnostics and Therapeutics Scope and Market Size
Exosome Diagnostics and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Exosome Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instrument
Reagent
Software

Segment by Application
Diagnostic
Therapeutic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instrument
1.2.3 Reagent
1.2.4 Software
1.3 Market by Application
1.3.1 Global Exosome Diagnostics and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Exosome Diagnostics and Therapeutics Market Perspective (2016-2027)
2.2 Exosome Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Exosome Diagnostics and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Exosome Diagnostics and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Exosome Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Exosome Diagnostics and Therapeutics Industry Dynamic
2.3.1 Exosome Diagnostics and Therapeutics Market Trends
2.3.2 Exosome Diagnostics and Therapeutics Market Drivers
2.3.3 Exosome Diagnostics and Therapeutics Market Challenges
2.3.4 Exosome Diagnostics and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Exosome Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Exosome Diagnostics and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Exosome Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Exosome Diagnostics and Therapeutics Revenue
3.4 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Diagnostics and Therapeutics Revenue in 2020
3.5 Exosome Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Exosome Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Exosome Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Exosome Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Exosome Diagnostics and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Exosome Diagnostics and Therapeutics Market Size (2016-2027)
6.2 North America Exosome Diagnostics and Therapeutics Market Size by Type
6.2.1 North America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
6.3 North America Exosome Diagnostics and Therapeutics Market Size by Application
6.3.1 North America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
6.4 North America Exosome Diagnostics and Therapeutics Market Size by Country
6.4.1 North America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Exosome Diagnostics and Therapeutics Market Size (2016-2027)
7.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type
7.2.1 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application
7.3.1 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Exosome Diagnostics and Therapeutics Market Size by Country
7.4.1 Europe Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Exosome Diagnostics and Therapeutics Market Size (2016-2027)
9.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Type
9.2.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Exosome Diagnostics and Therapeutics Market Size by Application
9.3.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Exosome Diagnostics and Therapeutics Market Size by Country
9.4.1 Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Aethlon Medical(US)
11.1.1 Aethlon Medical(US) Company Details
11.1.2 Aethlon Medical(US) Business Overview
11.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Introduction
11.1.4 Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.1.5 Aethlon Medical(US) Recent Development
11.2 Exosome Diagnostics(US)
11.2.1 Exosome Diagnostics(US) Company Details
11.2.2 Exosome Diagnostics(US) Business Overview
11.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Introduction
11.2.4 Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.2.5 Exosome Diagnostics(US) Recent Development
11.3 NanoSomix Inc.(US)
11.3.1 NanoSomix Inc.(US) Company Details
11.3.2 NanoSomix Inc.(US) Business Overview
11.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Introduction
11.3.4 NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.3.5 NanoSomix Inc.(US) Recent Development
11.4 Thermo Fisher Scientific (US)
11.4.1 Thermo Fisher Scientific (US) Company Details
11.4.2 Thermo Fisher Scientific (US) Business Overview
11.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Introduction
11.4.4 Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.4.5 Thermo Fisher Scientific (US) Recent Development
11.5 Malvern Instruments (UK)
11.5.1 Malvern Instruments (UK) Company Details
11.5.2 Malvern Instruments (UK) Business Overview
11.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Introduction
11.5.4 Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.5.5 Malvern Instruments (UK) Recent Development
11.6 System Biosciences(US)
11.6.1 System Biosciences(US) Company Details
11.6.2 System Biosciences(US) Business Overview
11.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Introduction
11.6.4 System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.6.5 System Biosciences(US) Recent Development
11.7 NX Pharmagen (US)
11.7.1 NX Pharmagen (US) Company Details
11.7.2 NX Pharmagen (US) Business Overview
11.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Introduction
11.7.4 NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.7.5 NX Pharmagen (US) Recent Development
11.8 Sistemic Inc(UK)
11.8.1 Sistemic Inc(UK) Company Details
11.8.2 Sistemic Inc(UK) Business Overview
11.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Introduction
11.8.4 Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.8.5 Sistemic Inc(UK) Recent Development
11.9 Capricor Therapeutics (US)
11.9.1 Capricor Therapeutics (US) Company Details
11.9.2 Capricor Therapeutics (US) Business Overview
11.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Introduction
11.9.4 Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.9.5 Capricor Therapeutics (US) Recent Development
11.10 Exiqon A/S (Denmark)
11.10.1 Exiqon A/S (Denmark) Company Details
11.10.2 Exiqon A/S (Denmark) Business Overview
11.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Introduction
11.10.4 Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021)
11.10.5 Exiqon A/S (Denmark) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instrument
Table 3. Key Players of Reagent
Table 4. Key Players of Software
Table 5. Global Exosome Diagnostics and Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Exosome Diagnostics and Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Exosome Diagnostics and Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Table 11. Exosome Diagnostics and Therapeutics Market Trends
Table 12. Exosome Diagnostics and Therapeutics Market Drivers
Table 13. Exosome Diagnostics and Therapeutics Market Challenges
Table 14. Exosome Diagnostics and Therapeutics Market Restraints
Table 15. Global Exosome Diagnostics and Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Exosome Diagnostics and Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Exosome Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2020)
Table 18. Ranking of Global Top Exosome Diagnostics and Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Exosome Diagnostics and Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Exosome Diagnostics and Therapeutics Product Solution and Service
Table 22. Date of Enter into Exosome Diagnostics and Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Exosome Diagnostics and Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Exosome Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Aethlon Medical(US) Company Details
Table 63. Aethlon Medical(US) Business Overview
Table 64. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product
Table 65. Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Aethlon Medical(US) Recent Development
Table 67. Exosome Diagnostics(US) Company Details
Table 68. Exosome Diagnostics(US) Business Overview
Table 69. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product
Table 70. Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Exosome Diagnostics(US) Recent Development
Table 72. NanoSomix Inc.(US) Company Details
Table 73. NanoSomix Inc.(US) Business Overview
Table 74. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product
Table 75. NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 76. NanoSomix Inc.(US) Recent Development
Table 77. Thermo Fisher Scientific (US) Company Details
Table 78. Thermo Fisher Scientific (US) Business Overview
Table 79. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product
Table 80. Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Thermo Fisher Scientific (US) Recent Development
Table 82. Malvern Instruments (UK) Company Details
Table 83. Malvern Instruments (UK) Business Overview
Table 84. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product
Table 85. Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Malvern Instruments (UK) Recent Development
Table 87. System Biosciences(US) Company Details
Table 88. System Biosciences(US) Business Overview
Table 89. System Biosciences(US) Exosome Diagnostics and Therapeutics Product
Table 90. System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 91. System Biosciences(US) Recent Development
Table 92. NX Pharmagen (US) Company Details
Table 93. NX Pharmagen (US) Business Overview
Table 94. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product
Table 95. NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 96. NX Pharmagen (US) Recent Development
Table 97. Sistemic Inc(UK) Company Details
Table 98. Sistemic Inc(UK) Business Overview
Table 99. Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Sistemic Inc(UK) Recent Development
Table 101. Capricor Therapeutics (US) Company Details
Table 102. Capricor Therapeutics (US) Business Overview
Table 103. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product
Table 104. Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Capricor Therapeutics (US) Recent Development
Table 106. Exiqon A/S (Denmark) Company Details
Table 107. Exiqon A/S (Denmark) Business Overview
Table 108. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product
Table 109. Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Exiqon A/S (Denmark) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Diagnostics and Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Instrument Features
Figure 3. Reagent Features
Figure 4. Software Features
Figure 5. Global Exosome Diagnostics and Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Diagnostic Case Studies
Figure 7. Therapeutic Case Studies
Figure 8. Exosome Diagnostics and Therapeutics Report Years Considered
Figure 9. Global Exosome Diagnostics and Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Exosome Diagnostics and Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Exosome Diagnostics and Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Exosome Diagnostics and Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Exosome Diagnostics and Therapeutics Market Share by Players in 2020
Figure 14. Global Top Exosome Diagnostics and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Exosome Diagnostics and Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Exosome Diagnostics and Therapeutics Revenue in 2020
Figure 16. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Exosome Diagnostics and Therapeutics Market Share by Region (2016-2027)
Figure 38. China Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Exosome Diagnostics and Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Exosome Diagnostics and Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Exosome Diagnostics and Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Exosome Diagnostics and Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Aethlon Medical(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 58. Exosome Diagnostics(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 59. NanoSomix Inc.(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 60. Thermo Fisher Scientific (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 61. Malvern Instruments (UK) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 62. System Biosciences(US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 63. NX Pharmagen (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 64. Sistemic Inc(UK) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 65. Capricor Therapeutics (US) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 66. Exiqon A/S (Denmark) Revenue Growth Rate in Exosome Diagnostics and Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---